In head and neck cancer patients, the upregulation of p38 expression and activation in the surgical resection margin of the tumor is associated with the expression of CSC markers (OCT4, KLF4, MYC, and CD44) and a higher frequency of relapse [135]. This evidence concerns the gene MYC and neoplasm.